JASPER THERAPEUTICS, INC. Increase (Decrease) in Accounts and Other Receivables
JASPER THERAPEUTICS, INC. (JSPR) reported Increase (Decrease) in Accounts and Other Receivables of -$663.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-05.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables · last filed 2024-03-05
- JASPER THERAPEUTICS, INC. increase (decrease) in accounts and other receivables for fiscal 2023 was -$663.00K, a 200.00% decline from fiscal 2022.
- JASPER THERAPEUTICS, INC. increase (decrease) in accounts and other receivables for fiscal 2022 was $663.00K.
| Period end | Increase (Decrease) in Accounts and Other Receivables 12 month |
|---|---|
| 2023-12-31 | -$663.00K 10-K · filed 2024-03-05 |
| 2022-12-31 | $663.00K 10-K · filed 2024-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |